EGFR and cholangiocarcinoma: Figure 8K and Additional file 3: Figure S3K, the number of mutated genes detected in tissues, arterial CTCs and venous CTCs in patients with cholangiocarcinoma was basically the same, the mutated genes targeted with clinically available drugs (EGFR exon19) were detected in tissues, arterial CTCs and venous CTCs at the same time.